Heterogeneity of genetic alterations in primary human breast tumors

Author(s):  
Iqbal Unnisa Ali ◽  
Rosette Lidereau ◽  
Robert Callahan
1994 ◽  
Vol 5 ◽  
pp. 7 ◽  
Author(s):  
M A Sognier ◽  
G A Altenberg ◽  
R Eberle ◽  
M Tucker ◽  
J A Belli

2007 ◽  
Vol 21 (6) ◽  
Author(s):  
Ashley G Rivenbark ◽  
Chad A Livasy ◽  
Courtney E Boyd ◽  
Daniel Keppler ◽  
William B Coleman

2004 ◽  
pp. 391-396 ◽  
Author(s):  
I Chatzistamou ◽  
AV Schally ◽  
H Kiaris ◽  
E Politi ◽  
J Varga ◽  
...  

OBJECTIVE: GHRH is secreted by the hypothalamus and, upon binding to specific GHRH receptors in the pituitary, stimulates growth hormone (GH) production and release from the pituitary. In addition to this neuroendocrine action, accumulated evidence implies additional roles for GHRH in carcinogenesis in non-pituitary tissues. In vitro and in vivo studies have shown that splice variant 1 (SV1) of the GHRH receptor, which is widely expressed in non-pituitary tissues and cancers, can mediate the proliferative effects of GHRH. The aim of the present study was to investigate the operation of an autocrine stimulatory loop between GHRH and SV1 in primary breast tumors. DESIGN: Fifty-three primary breast tumors were evaluated for GHRH and SV1 expression. METHODS: Expression of GHRH and SV1 was assessed by immunohistochemistry using anti-GHRH SV95 and anti-SV1 2317/5 polyclonal antibodies. RESULTS: About 40% of the specimens tested express GHRH and/or SV1 (approx. 25% each), while in 35% of these positive specimens co-expression of these antigens was detected (P<0.01). Furthermore, a correlation of GHRH, but not SV1, expression was detected in lobular compared with ductal carcinomas. CONCLUSIONS: These results constitute the first demonstration for the expression of GHRH and SV1 in primary breast cancers, and provide evidence for the operation of an autocrine stimulatory loop between GHRH and SV1 in primary cancers. Our findings indicate that GHRH analogs could have diagnostic and therapeutic applications for the management of breast cancer.


1994 ◽  
Vol 86 (15) ◽  
pp. 1167-1169 ◽  
Author(s):  
C. S. Cropp ◽  
R. Lidereau ◽  
A. Leone ◽  
D. Liscia ◽  
A. P. M. Cappa ◽  
...  

1993 ◽  
Vol 53 (S17G) ◽  
pp. 167-172 ◽  
Author(s):  
Robert Callahan ◽  
Craig Cropp ◽  
Zong Mei Sheng ◽  
Giorgio Merlo ◽  
Patricia Steeg ◽  
...  

Author(s):  
Rakesh Gurrala ◽  
C. Ethan Byrne ◽  
Loren M. Brown ◽  
Rafael Felix P. Tiongco ◽  
Margarite D. Matossian ◽  
...  

Solid tumor progression is significantly influenced by interactions between cancer cells and the surrounding extracellular matrix (ECM). Specifically, the cancer cell-driven changes to ECM fiber alignment and collagen deposition impact tumor growth and metastasis. Current methods of quantifying these processes are incomplete, require simple or artificial matrixes, rely on uncommon imaging techniques, preclude the use of biological and technical replicates, require destruction of the tissue, or are prone to segmentation errors. We present a set of methodological solutions to these shortcomings that were developed to quantify these processes in cultured, ex vivo human breast tissue under the influence of breast cancer cells and allow for the study of ECM in primary breast tumors. Herein, we describe a method of quantifying fiber alignment that can analyze complex native ECM from scanning electron micrographs that does not preclude the use of replicates and a high-throughput mechanism of quantifying collagen content that is non-destructive. The use of these methods accurately recapitulated cancer cell-driven changes in fiber alignment and collagen deposition observed by visual inspection. Additionally, these methods successfully identified increased fiber alignment in primary human breast tumors when compared to human breast tissue and increased collagen deposition in lobular breast cancer when compared to ductal breast cancer. The successful quantification of fiber alignment and collagen deposition using these methods encourages their use for future studies of ECM dysregulation in human solid tumors.


Gene ◽  
2004 ◽  
Vol 328 ◽  
pp. 135-142 ◽  
Author(s):  
Alex J. Bowers ◽  
John F. Boylan

1996 ◽  
Vol 28 (1) ◽  
pp. 47-53 ◽  
Author(s):  
Jae-won Joh ◽  
Dong-Young Noh ◽  
Chang-Dae Bae ◽  
Kuk-Jin Choi ◽  
Joo-Bae Park

Sign in / Sign up

Export Citation Format

Share Document